Belgium· BE-AMP-SAM335842-00
Crestor 40 mg
A rosuvastatin product containing rosuvastatin calcium, registered in Belgium by PI Pharma. The same ATC class is registered in 18 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Rosuvastatin is registered in 18 of 19 countries.
Countries holding a registration under ATC C10AA07 (rosuvastatin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 11 of them publish a price we can compare per daily dose
Rosuvastatin · ATC C10AA07
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of rosuvastatin costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.036 in United States to $0.73 in Switzerland — a ×20 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Rosuvastatin · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.73
- ES Spain$0.39
- IT Italy$0.26
- FR France$0.17
- US United States$0.036 (acquisition cost)
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Rosuvastatin Calcium
- Manufacturer
- PI Pharma
- Country
- Belgium (BE)
- ATC code
- C10AA07
- ATC class
- Rosuvastatin
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2630747
- be_apb0794180
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
689 interactions on record for rosuvastatin.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rosuvastatin · interactions on record
689 records
- 29 severe
- 200 moderate
- 20 minor
- 403 info
Most severe, free to view
- ClofibrateC10AB01severe
- GemfibrozilC10AB04severe
- FenofibrateC10AB05severe
- MipomersenC10AX11severe
37 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7864e5fc-b3b3-4a0b-9855-32733aaeb989 GET /v1/drugs/7864e5fc-b3b3-4a0b-9855-32733aaeb989?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Crestor 40 mg",
"name_fr": "Crestor 40 mg",
"name_nl": "Crestor 40 mg",
"amp_code": "SAM335842-00",
"strengths": [
"41.6000",
"40.0000"
],
"pack_count": 14,
"substances": [
"Rosuvastatin Calcium",
"Rosuvastatin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Rosuvastatin",
"authorisation_numbers": [
"1637PI0089F003"
]
}See everything about rosuvastatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.